PDCD1 and cancer: The introduction of immune checkpoint inhibitors (ICIs) as a “brake” on the immune system has provided a new option for patients with advanced cancer, and PD-1/PD-L1 inhibitors, the most commonly used immune checkpoint inhibitors, are widely used in the treatment of various cancers.